<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - LIDOCAINE HYDROCHLORIDE</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drug/">Drugs</a></li>
      </ul>

      <h1>LIDOCAINE HYDROCHLORIDE</h1>


      <nav>
        <ul class="nav nav-list">

          <li class="active"><a href="#indicationsAndDoses" data-toggle="tab">Indications and doses</a></li>
          <li><a href="#pregnancy" data-toggle="tab">Pregnancy</a></li>
          <li><a href="#hepaticImpairment" data-toggle="tab">Hepatic impairment</a></li>
          <li><a href="#renalImpairment" data-toggle="tab">Renal impairment</a></li>
          <li><a href="#contraindications" data-toggle="tab">Contra indications</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#importantSafetyInformation" data-toggle="tab">Important safety information</a></li>
          <li><a href="#cautions" data-toggle="tab">Cautions</a></li>
          <li><a href="#monitoringRequirements" data-toggle="tab">Monitoring requirements</a></li>
          <li><a href="#unlicensedUse" data-toggle="tab">Unlicensed use</a></li>
          <li><a href="#professionSpecificInformation" data-toggle="tab">Profession specific information</a></li>
          <li><a href="#allergyAndCrossSensitivity" data-toggle="tab">Allergy and cross sensitivity</a></li>
          <li><a href="#medicinalForms" data-toggle="tab">Medicinal forms</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">

      <section class="tab-pane active" id="indicationsAndDoses">
        <h2>Indications and doses</h2>

        <section class="indicationAndDoseGroups">
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Cardiopulmonary resuscitation (as an alternative if amiodarone is not available)</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous injection</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                1 mg/kg, do not exceed 3 mg/kg over the first hour.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Ventricular arrhythmias, especially after myocardial infarction in patients without gross circulatory impairment</span>,
            </h4>
            <p class="specificity"><span class="route">Initially by intravenous injection</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                100 mg, to be given as a bolus dose over a few minutes, followed immediately by (by intravenous infusion) 4 mg/minute for 30 minutes, then (by intravenous infusion) 2 mg/minute for 2 hours, then (by intravenous infusion) 1 mg/minute, reduce concentration further if infusion continued beyond 24 hours (ECG monitoring and specialist advice for infusion), following intravenous injection lidocaine has a short duration of action (lasting for 15&#8211;20 minutes). If an intravenous infusion is not immediately available the initial intravenous injection of 100 mg can be repeated if necessary once or twice at intervals of not less than 10 minutes.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Ventricular arrhythmias, especially after myocardial infarction in lighter patients or those whose circulation is severely impaired</span>,
            </h4>
            <p class="specificity"><span class="route">Initially by intravenous injection</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Initially 50 mg, to be given as a bolus dose over a few minutes, followed immediately by (by intravenous infusion) 4 mg/minute for 30 minutes, then (by intravenous infusion) 2 mg/minute for 2 hours, then (by intravenous infusion) 1 mg/minute, reduce concentration further if infusion continued beyond 24 hours (ECG monitoring and specialist advice for infusion), following intravenous injection lidocaine has a short duration of action (lasting for 15&#8211;20 minutes). If an intravenous infusion is not immediately available the initial intravenous injection of 50 mg can be repeated if necessary once or twice at intervals of not less than 10 minutes.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Infiltration anaesthesia</span>,
            </h4>
            <p class="specificity"><span class="route">By local infiltration</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Dose to be given according to patient's weight and nature of procedure; max. 200 mg, maximum dose 500 mg if given in solutions containing adrenaline.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Intravenous regional anaesthesia and nerve block</span>,
            </h4>
            <p class="specificity"><span class="route"></span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Seek expert advice.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Dental practice</span>,
            </h4>
            <p class="specificity"><span class="route">By buccal administration using ointment</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Rub gently into dry gum.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Relief of pain in oral lesions</span>,
            </h4>
            <p class="specificity"><span class="route">To the lesion using ointment</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Apply as required, rub sparingly and gently on affected areas.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Pain relief (in anal fissures, haemorrhoids, pruritus ani, pruritus vulvae, herpes zoster, or herpes labialis)</span>,
                <span class="indication">Lubricant in cystoscopy</span>,
                <span class="indication">Lubricant in proctoscopy</span>,
            </h4>
            <p class="specificity"><span class="route">To the skin using ointment</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Apply 1&#8211;2 mL as required, avoid long-term use.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Sore nipples from breast-feeding</span>,
            </h4>
            <p class="specificity"><span class="route">To the skin using ointment</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Apply using gauze and wash off immediately before next feed.</li>
            </ul>
          </section>
        </section>
        
        
        
            <section class="extremesOfBodyWeight">
                <h3>Doses at extremes of body-weight</h3>
              <p>To avoid excessive dosage in obese patients, dose may need to be calculated on the basis of ideal bodyweight.</p>
            </section>
        
        
      </section>



      <section class="tab-pane" id="pregnancy">
        <h2>Advice when patient is pregnant</h2>

            <section class="generalInformation">
              <p>Crosses the placenta but not known to be harmful in <i>animal</i> studies&#8212;use if benefit outweighs risk.</p><p>When used as a local anaesthetic, large doses can cause fetal bradycardia; if given during delivery can also cause neonatal respiratory depression, hypotonia, or bradycardia after paracervical or epidural block.</p>
            </section>
      </section>

      <section class="tab-pane" id="hepaticImpairment">
        <h2>Advice regarding hepatic impairment</h2>

            <section class="generalInformation">
              <p>Caution&#8212;increased risk of side-effects.</p>
            </section>
      </section>

      <section class="tab-pane" id="renalImpairment">
        <h2>Advice regarding renal impairment</h2>

        
            <section class="generalInformation">
              <p>Possible accumulation of lidocaine and active metabolite; caution in severe impairment.</p>
            </section>
      </section>

      <section class="tab-pane" id="contraindications">
        <h2>Contra indications</h2>

      </section>

      <section class="tab-pane" id="sideEffects">
        <h2>Known side effects</h2>

        
          <h3>Specific side effects</h3>
              <p>
                <strong>commonOrVeryCommon:</strong> bradycardia (may lead to cardiac arrest), confusion, convulsions, dizziness (particularly if injection too rapid), drowsiness (particularly if injection too rapid), hypotension (may lead to cardiac arrest), paraesthesia (particularly if injection too rapid), respiratory depression, bradycardia (may lead to cardiac arrest), confusion, convulsions, hypotension (may lead to cardiac arrest), respiratory depression,
              </p>
              <p>
                <strong>rare:</strong> anaphylaxis, anaphylaxis,
              </p>
              <p>
                <strong>notKnown:</strong> arrhythmias, blurred vision, cardiac arrest, feeling of inebriation, headache, hypoglycaemia (following intrathecal or extradural administration), methaemoglobinaemia, muscle twitching, myocardial depression (resulting in hypotension and bradycardia), nausea, numbness of the tongue and perioral region, nystagmus, peripheral vasodilatation (resulting in hypotension and bradycardia), rash, restlessness, tinnitus, transient excitation (followed by depression with drowsiness, respiratory failure, unconsciousness, and coma), tremors, vomiting,
              </p>
        
            <section class="advice">
              <h3 class="specificity">When used by <ph outputclass="route">regional administration</ph></h3>
                <p class="title">Toxic effects</p>
              <p>Toxic effects after administration of local anaesthetics are a result of excessively high plasma concentrations; severe toxicity usually results from inadvertent intravascular injection or too rapid injection.</p><p>Following most regional anaesthetic procedures, maximum arterial plasma concentration of anaesthetic develops within about 10 to 25 minutes, so careful surveillance for toxic effects is necessary during the first 30 minutes after injection.</p><p>The systemic toxicity of local anaesthetics mainly involves the central nervous and cardiovascular systems.</p>
            </section>
            <section class="advice">
                <h3>Topical application</h3>
              <p>A single application of a topical lidocaine preparation does not generally cause systemic side-effects.</p>
            </section>
            <section class="advice">
              <h3 class="specificity">When used by <ph outputclass="route">regional administration</ph></h3>
                <p class="title">Methaemoglobinaemia</p>
              <p>Methaemoglobinaemia can be treated with an intravenous injection of methylthioninium chloride; neonates and infants under 6 months are particularly susceptible to methaemoglobinaemia.</p>
            </section>
        
      </section>




      <section class="tab-pane" id="importantSafetyInformation">
        <h2>Important safety information</h2>

            <section class="importantSafetyInformation">
              <h3 class="specificity">When used by <ph outputclass="route">local infiltration</ph></h3>
              <p>The licensed doses stated may not be appropriate in some settings and expert advice should be sought.</p><p>Should only be administered by, or under the direct supervision of, personnel experienced in their use, with adequate training in anaesthesia and airway management, and should not be administered parenterally unless adequate resuscitation equipment is available.</p>
            </section>
      </section>

      <section class="tab-pane" id="cautions">
        <h2>Cautions regarding administration</h2>

        <ul>
          <li>
              <strong>With intravenous use:</strong>
            acute prophyria (consider infusion with glucose for its anti-porphyrinogenic effects)
          </li>
          <li>
              <strong>With intravenous use:</strong>
            congestive cardiac failure (consider lower dose)
          </li>
          <li>
              <strong>With intravenous use:</strong>
            post cardiac surgery (consider lower dose)
          </li>
          <li>
              <strong>With oral (topical) use:</strong>
            avoid anaesthesia of the pharynx before meals&#8212;risk of choking
          </li>
          <li>
              <strong>With oral (topical) use:</strong>
            can damage plastic cuffs of endotracheal tubes
          </li>
          <li>
              <strong>When used by regional administration:</strong>
            acute prophyria (consider infusion with glucose for its anti-porphyrinogenic effects)
          </li>
          <li>
              <strong>When used by regional administration:</strong>
            congestive cardiac failure (consider lower dose)
          </li>
          <li>
              <strong>When used by regional administration:</strong>
            debilitated patients (consider dose reduction)
          </li>
          <li>
              <strong>When used by regional administration:</strong>
            elderly
          </li>
          <li>
              <strong>When used by regional administration:</strong>
            elderly (consider dose reduction)
          </li>
          <li>
              <strong>When used by regional administration:</strong>
            epilepsy
          </li>
          <li>
              <strong>When used by regional administration:</strong>
            hypovolaemia
          </li>
          <li>
              <strong>When used by regional administration:</strong>
            impaired cardiac conduction
          </li>
          <li>
              <strong>When used by regional administration:</strong>
            impaired respiratory function
          </li>
          <li>
              <strong>When used by regional administration:</strong>
            myasthenia gravis
          </li>
          <li>
              <strong>When used by regional administration:</strong>
            post cardiac surgery (consider lower dose)
          </li>
          <li>
              <strong>When used by regional administration:</strong>
            shock
          </li>
        </ul>
      </section>


      <section class="tab-pane" id="monitoringRequirements">
        <h2>Monitoring requirements</h2>

        
          <h3>Patient parameters</h3>
        
            <section class="patientParameters">
              <h3 class="specificity">With <ph outputclass="route">systemic</ph> use</h3>
              <p>Monitor ECG and have resuscitation facilities available.</p>
            </section>
      </section>

      <section class="tab-pane" id="unlicensedUse">
        <h2>Unlicensed use</h2>

            <section class="unlicensedUse">
              <h3 class="specificity">With <ph outputclass="route">oral (topical)</ph> use</h3>
              <p>Spray not licensed for the relief of pain in oral lesions.</p>
            </section>
      </section>







      <section class="tab-pane" id="professionSpecificInformation">
        <h2>Profession specific information</h2>

          <h3>Dental practitioners</h3>
        
            <section class="dentalPractitionersFormulary">
              <p>Lidocaine ointment 5% may be prescribed.</p><p>Spray may be prescribed as Lidocaine Spray 10%</p>
            </section>
      </section>


      <section class="tab-pane" id="allergyAndCrossSensitivity">
        <h2>Advice regarding allergies and cross sensitivities</h2>

        
            <section class="crossSensitivity">
                <h3>Hypersensitivity and cross-sensitivity</h3>
              <p>Hypersensitivity reactions occur mainly with the ester-type local anaesthetics, such as tetracaine and chloroprocaine; reactions are less frequent with the amide types, such as articaine, bupivacaine, levobupivacaine, lidocaine, mepivacaine, prilocaine, and ropivacaine. Cross-sensitivity reactions may be avoided by using the alternative chemical type.</p>
            </section>
      </section>

      <section class="tab-pane" id="medicinalForms">
        <h2>Prepared medicinal forms of LIDOCAINE HYDROCHLORIDE</h2>


            <section class="licensingVariationStatement">
              <p>There can be variation in the licensing of different medicines containing the same drug.</p>
            </section>
        
          <strong>Forms available from special-order manufacturers include: </strong>
            solution for injection,
            gel,
            ointment,
            liquid,
            nebuliser liquid,
            mouthwash,
            lozenge,

            <div id="PHP74906"><a href="../medicinalForm/PHP74906.html" data-target="#PHP74906" data-action="load">Solution for injection</a></div>
            <div id="PHP74930"><a href="../medicinalForm/PHP74930.html" data-target="#PHP74930" data-action="load">Liquid</a></div>
            <div id="PHP74922"><a href="../medicinalForm/PHP74922.html" data-target="#PHP74922" data-action="load">Cream</a></div>
            <div id="PHP74927"><a href="../medicinalForm/PHP74927.html" data-target="#PHP74927" data-action="load">Ointment</a></div>
            <div id="PHP74912"><a href="../medicinalForm/PHP74912.html" data-target="#PHP74912" data-action="load">Spray</a></div>
            <div id="PHP74916"><a href="../medicinalForm/PHP74916.html" data-target="#PHP74916" data-action="load">Medicated plaster</a></div>
      </section>
    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
  <script src="/content/scripts/NICE.RemoteLoad.js"></script>
</html>
